Prevention of hyperacute rejection by phosphatidylinositol-anchored mini-complement receptor type 1

By Mikata S.   Miyagawa S.   Yoshitatsu M.   Ikawa M.   Okabe M.   Matsuda H.   Shirakura R.  

Transplant Immunology, Vol. 6, Iss. 2, 1998-06 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Construction, Function and In Vivo Expression of a Complement Receptor Type 1 Containing Recombinant Adenovirus for Use In Xenotransplantation

By Tabei I.   Elfeki S.G.   Nakamura J.   Hammel J.M.   Fearon D.T.   Graham F.   Fox I.J.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 933-934

Elsevier

Access to resources Recommend Favorite

Soluble Complement Receptor Type 1 and Antithrombin-III Combination Therapy Prolongs Xenograft Survival: The Role of Thrombin and Prostacyclin in Hyperacute Rejection

By Fujiwara I.   Nakajima H.   Akioka K.   Matsuda T.   Oka T.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 935-937

Elsevier

Access to resources Recommend Favorite

Human complement receptor type 1 (CR1) binds to a major malarial adhesin

By Krych-Goldberg M.   Moulds J.M.   Atkinson J.P.  

Trends in Molecular Medicine, Vol. 8, Iss. 11, 2002-11 ,pp. : 531-537

Elsevier

Access to resources Recommend Favorite

Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients

By Kremlitzka Mariann  

International Immunology, Vol. 25, Iss. 1, 2013-01 ,pp. : 25-33

Oxford University Press

Access to resources Recommend Favorite